Publicacións en colaboración con investigadores/as de Centro Nacional de Epidemiología (88)

2024

  1. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  2. Prevalence and Phenotypic Susceptibility to Doravirine of the HIV-1 Reverse Transcriptase V106I Polymorphism in B and Non-B Subtypes

    Journal of Infectious Diseases, Vol. 229, Núm. 6, pp. 1796-1802

  3. Towards stronger tobacco control policies to curb the smoking epidemic in Spain

    Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1561-1569

2023

  1. Changes in smoking cessation in Spain, 1987-2020

    Medicina Clinica, Vol. 160, Núm. 6, pp. 237-244

  2. Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer” (eBioMedicine (2023) 92, (S2352396423001810), (10.1016/j.ebiom.2023.104616))

    eBioMedicine

  3. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  4. Dissecting the genetic heterogeneity of gastric cancer

    eBioMedicine, Vol. 92

  5. Estimations of smoking-attributable mortality in Spain at a regional level: comparison of two methods

    Annals of Epidemiology, Vol. 82, pp. 77-83.e3

  6. Light cigarette smoking and all-cause mortality in Spain. A national population-based cohort study

    Annals of Epidemiology, Vol. 78, pp. 9-12

  7. Small-area models to assess the geographical distribution of tobacco consumption by sex and age in Spain

    Tobacco Induced Diseases, Vol. 21, Núm. May

  8. The duration of intervals on the oral cancer care pathway and implications for survival: a systematic review and meta-analysis

    Frontiers in Public Health, Vol. 11

2022

  1. Methodological guidelines for the estimation of attributable mortality using a prevalence-based method: the STREAMS-P tool

    Journal of Clinical Epidemiology, Vol. 147, pp. 101-110

  2. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

  3. Smoking-attributable mortality in the autonomous communities of Spain, 2017

    Revista Espanola de Cardiologia, Vol. 75, Núm. 2, pp. 150-158

  4. Trends in smoking-attributable mortality in Spain: 1990-2018

    European journal of public health, Vol. 32, Núm. 6, pp. 919-925

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  2. Late presentation for HIV remains a major health issue in Spain: Results from a multicenter cohort study, 2004–2018

    PLoS ONE, Vol. 16, Núm. 4 April

2020

  1. Author Correction: Validating a breast cancer score in Spanish women. The MCC-Spain study (Scientific Reports, (2018), 8, 1, (3036), 10.1038/s41598-018-20832-0)

    Scientific Reports

  2. Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study

    AIDS Research and Therapy, Vol. 17, Núm. 1

  3. Smoking-Attributable Mortality in Spain in 2016

    Archivos de Bronconeumologia, Vol. 56, Núm. 9, pp. 559-563